Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 787

1.

Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor.

Kristiansen W, Karlsson R, Rounge TB, Whitington T, Andreassen BK, Magnusson PK, Fosså SD, Adami HO, Turnbull C, Haugen TB, Grotmol T, Wiklund F.

Hum Mol Genet. 2015 Apr 15. pii: ddv129. [Epub ahead of print]

PMID:
25877299
2.

Chronic fatigue is prevalent and associated with hormonal dysfunction in long term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region.

Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE.

Leuk Lymphoma. 2015 Apr 1:1-29. [Epub ahead of print]

PMID:
25827172
3.

Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.

Hjelle LV, Gundersen PO, Oldenburg J, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Bremnes RM, Haugnes HS.

Anticancer Res. 2015 Mar;35(3):1619-25.

PMID:
25750319
4.

Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE.

J Cancer Surviv. 2015 Mar 7. [Epub ahead of print]

PMID:
25750158
5.

Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.

Brabrand S, Johannessen B, Axcrona U, Kraggerud SM, Berg KG, Bakken AC, Bruun J, Fosså SD, Lothe RA, Lehne G, Skotheim RI.

Neoplasia. 2015 Feb;17(2):167-74. doi: 10.1016/j.neo.2014.12.005.

6.

Providing information about late effects after childhood cancer: Lymphoma survivors' preferences for what, how and when.

Lie HC, Loge JH, Fosså SD, Hamre HM, Hess SL, Mellblom AV, Ruud E, Finset A.

Patient Educ Couns. 2015 May;98(5):604-11. doi: 10.1016/j.pec.2015.01.016. Epub 2015 Jan 31.

PMID:
25704291
7.

Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure - Relationship to cardiac radiation dose and cardiovascular risk factors.

Tjessem KH, Bosse G, Fosså K, Reinertsen KV, Fosså SD, Johansen S, Fosså A.

Radiother Oncol. 2015 Mar;114(3):328-34. doi: 10.1016/j.radonc.2015.01.006. Epub 2015 Jan 16.

PMID:
25600105
8.

Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223.

Nome R, Hernes E, Bogsrud TV, Bjøro T, Fosså SD.

Scand J Urol. 2014 Dec 17:1-7. [Epub ahead of print]

PMID:
25515952
9.

Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".

Solheim O, Tropé CG, Rokkones E, Kærn J, Paulsen T, Salvesen HB, Hagen B, Vereide AB, Fosså SD.

Gynecol Oncol. 2015 Feb;136(2):224-9. doi: 10.1016/j.ygyno.2014.12.010. Epub 2014 Dec 12.

PMID:
25511159
10.

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology.

Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11.

PMID:
25498218
11.

Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA.

Scand J Urol. 2014 Nov 27:1-10. [Epub ahead of print]

PMID:
25428752
12.

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.

Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fosså SD, Germà-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruš D, Rosti G, Stephenson AJ, Tandstad T; On behalf of: SWENOTECA (Swedish Norwegian Testicular Cancer group), the Italian Germ Cell Cancer Group (IGG), Spanish Germ Cell Cancer Group (SGCCG).

Ann Oncol. 2015 May;26(5):833-838. Epub 2014 Nov 6. Review.

13.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

PMID:
25349972
14.

Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.

Aschim EL, Oldenburg J, Kristiansen W, Giwercman A, Witczak O, Fosså SD, Haugen TB.

Hum Reprod. 2014 Dec;29(12):2844-51. doi: 10.1093/humrep/deu274. Epub 2014 Oct 21.

PMID:
25336703
15.

Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital.

Fosså SD, Hess SL, Paus E, Borgen E.

Res Rep Urol. 2014 Sep 27;6:121-6. doi: 10.2147/RRU.S68477. eCollection 2014.

16.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

17.

Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients.

Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA.

Acta Orthop. 2014 Dec;85(6):652-6. doi: 10.3109/17453674.2014.963784. Epub 2014 Sep 19.

18.

Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery.

Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD.

J Cancer Surviv. 2014 Sep 13. [Epub ahead of print]

PMID:
25216609
19.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

PMID:
25185241
20.

Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.

Kiserud CE, Seland M, Holte H, Fosså A, Fosså SD, Bollerslev J, Bjøro T, Loge JH.

Acta Oncol. 2015 Jan;54(1):49-59. doi: 10.3109/0284186X.2014.948057. Epub 2014 Aug 20.

PMID:
25140862
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk